Gene · 54578
Papers1,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug-drug interaction studies. | Clin Transl Sci | 2022 | 35722783 | PubTator, text mining | PubMed |
| Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in rats. | Toxicol Lett | 2022 | 35654319 | PubTator, text mining | PubMed |
| Morphine-3-Glucuronide, Physiology and Behavior. | Front Mol Neurosci | 2022 | 35645730 | PubTator, text mining | PubMed |
| The inhibition of tamoxifen on UGT2B gene expression and enzyme activity in rat liver contribute to the estrogen homeostasis dysregulation. | BMC Pharmacol Toxicol | 2022 | 35642027 | PubTator, text mining | PubMed |
| Comprehensive network analysis of dysregulated genes revealed MNX1-AS1/hsa-miR-4697-3p/HOXB13 axis in ovarian cancer chemotherapy response. | Cancer Sci | 2022 | 35639251 | PubTator, text mining | PubMed |
| Association of Genetic Polymorphisms with Complications of Implanted LVAD Devices in Patients with Congestive Heart Failure: A Kazakhstani Study. | J Pers Med | 2022 | 35629166 | PubTator, text mining | PubMed |
| Common UGT1A6 Variant Alleles Determine Acetaminophen Pharmacokinetics in Man. | J Pers Med | 2022 | 35629143 | PubTator, text mining | PubMed |
| Smoking Impairs Hematoma Formation and Dysregulates Angiogenesis as the First Steps of Fracture Healing. | Bioengineering (Basel) | 2022 | 35621464 | PubTator, text mining | PubMed |
| Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line. | Clin Proteomics | 2022 | 35568821 | PubTator, text mining | PubMed |
| Effects of Functional Phenolics Dietary Supplementation on Athletes' Performance and Recovery: A Review. | Int J Mol Sci | 2022 | 35563043 | PubTator, text mining | PubMed |
| Consensus molecular subtype differences linking colon adenocarcinoma and obesity revealed by a cohort transcriptomic analysis. | PLoS One | 2022 | 35560039 | PubTator, text mining | PubMed |
| Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives. | Acta Pharm Sin B | 2022 | 35530147 | PubTator, text mining | PubMed |
| Genetics of Anthracycline-Associated Cardiotoxicity. | Front Cardiovasc Med | 2022 | 35528837 | PubTator, text mining | PubMed |
| Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets. | Front Cardiovasc Med | 2022 | 35528835 | PubTator, text mining | PubMed |
| Case Report: Diffuse Large B Cell Lymphoma After Cardiac Transplantation due to Anthracycline-Induced Dilated Cardiomyopathy in Pediatric Acute Lymphoblastic Leukemia. | Front Pharmacol | 2022 | 35517799 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis. | Clin Pharmacol Ther | 2022 | 35510337 | PubTator, text mining | PubMed |
| Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients. | Pharmaceutics | 2022 | 35456645 | PubTator, text mining | PubMed |
| Toxicokinetics of β-Amanitin in Mice and In Vitro Drug-Drug Interaction Potential. | Pharmaceutics | 2022 | 35456608 | PubTator, text mining | PubMed |
| Metabolic conjugation reduces in vitro toxicity of the flavonoid nevadensin. | Food Chem Toxicol | 2022 | 35436549 | PubTator, text mining | PubMed |
| Genetic testing of UGT1A1 in the diagnosis of Gilbert syndrome: The discovery of seven novel variants in the Chinese population. | Mol Genet Genomic Med | 2022 | 35426266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54578/papers?page=13